298. Hereditary pancreatitis
93 clinical trials,   168 drugs   (DrugBank: 51 drugs),   48 drug target genes,   134 drug target pathways

Searched query = "Hereditary pancreatitis", "Chronic pancreatitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01551511
(ClinicalTrials.gov)
October 20127/2/2012?9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain?9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain: a Randomized, Double-blinded, Placebo-controlled, Parallel DesignPancreatitis, Chronic;Abdominal Pain;Chronic PainDrug: Tetrahydrocannabinol;Drug: PlaceboRadboud UniversityEuropean UnionCompleted18 YearsN/ABoth29Phase 2Netherlands
2EUCTR2012-000730-19-NL
(EUCTR)
23/08/201212/03/2012?9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal PainThe analgesic efficacy of ?9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain: a Randomized, Double-blinded, Placebo-controlled, Parallel Design - Delta-Pain II Chronic pancreatitis with persistant abdominal pain
MedDRA version: 14.1;Level: PT;Classification code 10033649;Term: Pancreatitis chronic;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]
Product Name: Namisol
Product Code: A04AD10
INN or Proposed INN: DRONABINOL
Other descriptive name: Tetrahydro-6,6,9-tri methyl-3-penthyl-6 H-dibenzo[ b,d ]pyran-1-ol
Radboud University Nijmegen Medical CentreNULLNot RecruitingFemale: yes
Male: yes
68Phase 2Netherlands
3NCT01318369
(ClinicalTrials.gov)
October 20119/3/2011Efficacy Study of ?9-THC to Treat Chronic Abdominal PainThe Safety, Tolerability, and Analgesic Efficacy of ?9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal PainCannabinoid;Tetrahydrocannabinol;Chronic Pancreatitis;Abdominal PainDrug: Namisol;Drug: DiazepamRadboud UniversityNULLCompleted18 YearsN/ABoth24Phase 2Netherlands
4EUCTR2011-000647-24-NL
(EUCTR)
26/07/201112/05/2011Efficacy study of ?9-THC to treat persistent abdominal pain as a result of chronic pancreas inflammationThe safety, tolerability, and analgesic efficacy of ?9-THC (Namisol®) in chronic pancreatitis patients suffering from persistent abdominal pain - ?9-THC in chronic pain patients with abdominal pain as a result of chronic pancreatitis
MedDRA version: 13.1;Level: PT;Classification code 10033649;Term: Pancreatitis chronic;System Organ Class: 10017947 - Gastrointestinal disorders
MedDRA version: 13.1;Level: LLT;Classification code 10009093;Term: Chronic pancreatitis;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: Namisol
Product Code: A04AD10
INN or Proposed INN: DRONABINOL
Radboud University Nijmegen Medical CentreNULLNot RecruitingFemale: no
Male: yes
Netherlands